ELITechGroup is now a Bruker company. Read the press release here.

Choose your sales office

PRODUCT NEWS

Our new Molecular MDR/MTB multiplex assay

width=
Een high performance based on our MGB® technology:
– MTB complex: M.tuberculosis, M.africanum, M.bovis, M.canetti, M.microti, M.caprae.
– MGB resistence: Rifampicine en Izoniazide.
– Ultra sensitive: 6CFU/ml!
– Ready to use monoreagent.
In combination with our RT-PCR Sample-to-Result ELITe InGenius the most flexible solution for the diagnosis of Tuberculosis.

“

Latest news

NEWSROOM

Validation of our Amoebiasis kits published in Journal of Clinical Microbiology

ELITechGroup Microbiology is pleased to announce that a recent study published in the Journal of Clinical Microbiology (DOI: 10.1128/jcm.00179-25) confirms the strong performance of the serological assays ELI.H.A Amoeba and ELITex Bicolor Amoeba, designed for the diagnosis of Entamoeba histolytica for amoebiasis infections. This evaluation compared four commercial assays across…
READ MORE

ELITechGroup Announces Regulatory Approval of its Blood Borne Virus Panel in Japan

ELITechGroup’s blood-borne virus (BBV) panel received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) The ELITe BBV panel was launched in 2022 and comprises three quantitative IVD assays targeting Human Immunodeficiency virus-1 (HIV-1), Human Hepatitis B Virus (HBV), and Human Hepatitis C Virus (HCV) Turin, June 13, 2024: ELITechGroup…
READ MORE

Let us help you

For general inquiries, please use the links to the right. The Contact link leads to a brief online form, and the Support link offers general phone and email information. Someone will be in touch with you soon.

Contact